Skip to main content

Table 2 Association of PTR with patient overall survival in locally advanced PDA patients

From: Comparative effectiveness of primary tumor resection in patients with stage III pancreatic adenocarcinoma

 

OS

DSS

Number

HR (95%CI)

P value

Number

HR (95% CI)

P value

Non-adjusted

4322

0.61 (0.55, 0.68)

< 0.001

4055

0.60 (0.54, 0.66)

< 0.001

Multivariable adjusted model*

4322

0.59 (0.53, 0.66)

< 0.001

4055

0.57 (0.51, 0.65)

< 0.001

Matched on propensity score

960

0.59 (0.50, 0.69)

< 0.001

960

0.57 (0.47, 0.67)

< 0.001

Regression adjusted with propensity score

 Propensity score, continuous

4322

0.61 (0.55, 0.67)

< 0.001

4055

0.61 (0.54, 0.68)

< 0.001

 Propensity score, quintile

4322

0.62 (0.56, 0.69)

< 0.001

4055

0.60 (0.53, 0.67)

< 0.001

  1. PTR was the reference (HR: 1). Data are shown as HR (95% CI) P value. *Adjusted model was adjusted for: age, race, sex, year of diagnosis, tumor differentiation, tumor size, tumor location and chemotherapy
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us